Recruiting

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

I8B-FH-ITSD - ClinicalTrials.gov - NCT03952130

The purpose of this study is to see if LY900014 compared to insulin lispro (Humalog), both in combination with insulin glargine or insulin degludec, is safe and effective in participants with type 1 diabetes (T1D).
How long will I be in the trial?
The study will last about 39 weeks and may include up to 19 visits.
Email
Recruiting

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

I8B-FH-ITSD - ClinicalTrials.gov - NCT03952130

The purpose of this study is to see if LY900014 compared to insulin lispro (Humalog), both in combination with insulin glargine or insulin degludec, is safe and effective in participants with type 1 diabetes (T1D).
How long will I be in the trial?
The study will last about 39 weeks and may include up to 19 visits.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have T1D for at least 1 year prior to screening and continuously using insulin for at least 1 year

Participants must have Hemoglobin A1c (HbA1c) of ≥7.0 and ≤10.0%

Participants must have been treated for at least 90 days prior to screening with either multiple daily injection(s) (MDI) or premixed analog/human insulin regimens at least twice daily

Participants must have body mass index (BMI) of ≤35.0 kilograms per square meter (kg/m2)

Participants must NOT

Participants must not have used other anti-hyperglycemic medications or therapies (inhaled, oral or injectable) except for metformin within 90-days of screening

Participants must not have had more than 1 severe hypoglycemic episode within 6 months of screening

Participants must not have had more than 1 hospitalization related to hyperglycemia or diabetic ketoacidosis within 6 months of screening

Trial Summary

Conditions the trial is for

Type 1 Diabetes

What the trial is testing?

LY900014, Insulin Lispro, Insulin Glargine, Insulin Degludec

Could I receive a Placebo?

no

Enrollment Goal

350

Trial Dates

May 2019 - May 2022

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have T1D for at least 1 year prior to screening and continuously using insulin for at least 1 year

Participants must have Hemoglobin A1c (HbA1c) of ≥7.0 and ≤10.0%

Participants must have been treated for at least 90 days prior to screening with either multiple daily injection(s) (MDI) or premixed analog/human insulin regimens at least twice daily

Participants must have body mass index (BMI) of ≤35.0 kilograms per square meter (kg/m2)

Participants must NOT

Participants must not have used other anti-hyperglycemic medications or therapies (inhaled, oral or injectable) except for metformin within 90-days of screening

Participants must not have had more than 1 severe hypoglycemic episode within 6 months of screening

Participants must not have had more than 1 hospitalization related to hyperglycemia or diabetic ketoacidosis within 6 months of screening

Trial Summary

Conditions the trial is for

Type 1 Diabetes

What the trial is testing?

LY900014, Insulin Lispro, Insulin Glargine, Insulin Degludec

Could I receive a Placebo?

no

Enrollment Goal

350

Trial Dates

May 2019 - May 2022

Trial Phase

3

Not the right fit? Sign up to receive updates on new Type 1 Diabetes trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Type 1 Diabetes Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?